Structure Determinants Defining the Specificity of Papain-like Cysteine Proteases

Overview

Journal Comput Struct Biotechnol J

Specialty Biotechnology

Date 2022 Dec 5

PMID 36467578

Authors

Anastasiia I Petushkova

Lyudmila V Savvateeva

Andrey A Zamyatnin Jr

Affiliations

Soon will be listed here.

Abstract

Papain-like cysteine proteases are widely expressed enzymes that mostly regulate protein turnover in the acidic conditions of lysosomes. However, in the last twenty years, these proteases have been evidenced to exert specific functions within different organelles as well as outside the cell. The most studied proteases of this family are human cysteine cathepsins involved both in physiological and pathological processes. The specificity of each protease to its substrates is mostly defined by the structure of the binding cleft. Different patterns of amino acid motif in this area determine the interaction between the protease and the ligands. Moreover, this specificity can be altered under the specific media conditions and in case other proteins are present. Understanding how this network works would allow researchers to design the diagnostic selective probes and therapeutic inhibitors. Moreover, this knowledge might serve as a key for redesigning and engineering of the proteases for a wide range of applications.

Citing Articles

Structural insights into the role of the prosegment binding loop in a papain-superfamily cysteine protease from Treponema denticola.

Clark N, Li C, Malkowski M Acta Crystallogr F Struct Biol Commun. 2025; 81(Pt 2):53-61.

PMID: 39846228 PMC: 11783177. DOI: 10.1107/S2053230X25000378.

A bipartite bacterial virulence factor targets the complement system and neutrophil activation.

Kurniyati K, Clark N, Wang H, Deng Y, Sze C, Visser M EMBO J. 2025; 44(4):1154-1184.

PMID: 39753953 PMC: 11833123. DOI: 10.1038/s44318-024-00342-8.

Advances in Cysteine Protease B Inhibitors for Leishmaniasis Treatment.

Gini A, Emilio Joao E, Lopes J, Da Cunha P, Velasquez A, Graminha M Curr Drug Targets. 2024; 26(2):88-108.

PMID: 39350405 DOI: 10.2174/0113894501324437240919064715.

Identification of Dual Inhibitors Targeting Main Protease (M) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents.

Previti S, Ettari R, Calcaterra E, Roggia M, Natale B, Weldert A ACS Med Chem Lett. 2024; 15(5):602-609.

PMID: 38746883 PMC: 11089542. DOI: 10.1021/acsmedchemlett.3c00562.

Plant and Arthropod IgE-Binding Papain-like Cysteine Proteases: Multiple Contributions to Allergenicity.

Giangrieco I, Ciardiello M, Tamburrini M, Tuppo L, Mari A, Alessandri C Foods. 2024; 13(5).

PMID: 38472904 PMC: 10931198. DOI: 10.3390/foods13050790.

References

Kakegawa H, Nikawa T, Tagami K, Kamioka H, Sumitani K, Kawata T . Participation of cathepsin L on bone resorption. FEBS Lett. 1993; 321(2-3):247-50. DOI: 10.1016/0014-5793(93)80118-e. View

Desmarais S, Masse F, Percival M . Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools. Biol Chem. 2009; 390(9):941-8. DOI: 10.1515/BC.2009.092. View

Guncar G, Klemencic I, Turk B, Turk V, Juliano L, Turk D . Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease. Structure. 2000; 8(3):305-13. DOI: 10.1016/s0969-2126(00)00108-8. View

Stack C, Dalton J, Robinson M . The phylogeny, structure and function of trematode cysteine proteases, with particular emphasis on the Fasciola hepatica cathepsin L family. Adv Exp Med Biol. 2011; 712:116-35. DOI: 10.1007/978-1-4419-8414-2_8. View

Kovalenko I, Khrushchev S, Fedorov V, Riznichenko G, Rubin A . The role of electrostatic interactions in the process of diffusional encounter and docking of electron transport proteins. Dokl Biochem Biophys. 2016; 468(1):183-6. DOI: 10.1134/S1607672916030066. View

Zhao B, Janson C, Amegadzie B, DAlessio K, Griffin C, Hanning C . Crystal structure of human osteoclast cathepsin K complex with E-64. Nat Struct Biol. 1997; 4(2):109-11. DOI: 10.1038/nsb0297-109. View

Stoka V, Nycander M, Lenarcic B, Labriola C, Cazzulo J, BJORK I . Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily. FEBS Lett. 1995; 370(1-2):101-4. DOI: 10.1016/0014-5793(95)00798-e. View

Goldsmith M, Aggarwal N, Ashani Y, Jubran H, Greisen P, Ovchinnikov S . Overcoming an optimization plateau in the directed evolution of highly efficient nerve agent bioscavengers. Protein Eng Des Sel. 2017; 30(4):333-345. DOI: 10.1093/protein/gzx003. View

Poreba M, Groborz K, Vizovisek M, Maruggi M, Turk D, Turk B . Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples. Chem Sci. 2019; 10(36):8461-8477. PMC: 6839509. DOI: 10.1039/c9sc00997c. View

10.

Nosaka A, Kanaori K, Teno N, Togame H, Inaoka T, Takai M . Conformational studies on the specific cleavage site of Type I collagen (alpha-1) fragment (157-192) by cathepsins K and L by proton NMR spectroscopy. Bioorg Med Chem. 1999; 7(2):375-9. DOI: 10.1016/s0968-0896(98)00227-2. View

11.

Somoza J, Palmer J, Ho J . The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators. J Mol Biol. 2002; 322(3):559-68. DOI: 10.1016/s0022-2836(02)00780-5. View

12.

Barrett A . The cystatins: a diverse superfamily of cysteine peptidase inhibitors. Biomed Biochim Acta. 1986; 45(11-12):1363-74. View

13.

Baeyens-Volant D, Matagne A, El Mahyaoui R, Wattiez R, Azarkan M . A novel form of ficin from Ficus carica latex: Purification and characterization. Phytochemistry. 2015; 117:154-167. DOI: 10.1016/j.phytochem.2015.05.019. View

14.

Gorter J, Gruber M . Cathepsin C: an allosteric enzyme. Biochim Biophys Acta. 1970; 198(3):546-55. DOI: 10.1016/0005-2744(70)90132-4. View

15.

LaLonde J, Zhao B, Smith W, Janson C, DesJarlais R, Tomaszek T . Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites. J Med Chem. 1998; 41(23):4567-76. DOI: 10.1021/jm980249f. View

16.

Duncan E, Muratore-Schroeder T, Cook R, Garcia B, Shabanowitz J, Hunt D . Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell. 2008; 135(2):284-94. PMC: 2579750. DOI: 10.1016/j.cell.2008.09.055. View

17.

Rebernik M, Lenarcic B, Novinec M . The catalytic domain of cathepsin C (dipeptidyl-peptidase I) alone is a fully functional endoprotease. Protein Expr Purif. 2019; 157:21-27. DOI: 10.1016/j.pep.2019.01.009. View

18.

Harrach T, Eckert K, Nuck R, Grunow D, Maurer H . Isolation and partial characterization of basic proteinases from stem bromelain. J Protein Chem. 1995; 14(1):41-52. DOI: 10.1007/BF01902843. View

19.

Stack C, Caffrey C, Donnelly S, Seshaadri A, Lowther J, Tort J . Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica. J Biol Chem. 2007; 283(15):9896-908. PMC: 3979170. DOI: 10.1074/jbc.M708521200. View

20.

Rozman J, Stojan J, Kuhelj R, Turk V, Turk B . Autocatalytic processing of recombinant human procathepsin B is a bimolecular process. FEBS Lett. 1999; 459(3):358-62. DOI: 10.1016/s0014-5793(99)01302-2. View